SCHEMBL10035728

SCHEMBL10035728

CC(C)[C@H]1OC(=O)[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17973347 1.00 — —
SCHEMBL10110534 0.87 MEN1 (0.31) —
SCHEMBL13589504 0.83 — —
SCHEMBL1106083 0.83 — —
SCHEMBL12833579 0.78 HIF1A (0.34) —
SCHEMBL14503356 0.78 — —
SCHEMBL13120130 0.78 HIF1A (0.35) —
SCHEMBL677557 0.78 — —
SCHEMBL13105442 0.78 HIF1A (0.35) —
SCHEMBL20308636 0.73 THRB (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119653-B2 Belactosin derivatives as therapeutic agents/biological probes and their synthesis THE TEXAS A&M UNIVERSITY SYSTEM (US) 2012-02-21 — — US disclosed
US-20090042922-A1 NOVEL BELACTOSIN DERIVATIVES AS THERAPEUTIC AGENTS/BIOLOGICAL PROBES AND THEIR SYNTHESIS NATIONAL SCIENCE FOUNDATION 2009-02-12 — — US disclosed
Send feedback